|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Trade receivables, net | ||||||||||||||||||||
| Inventories: | ||||||||||||||||||||
| Materials | ||||||||||||||||||||
| Work in process | ||||||||||||||||||||
| Finished products | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, Plant and Equipment | ||||||||||||||||||||
| Less allowances for depreciation and amortization | ||||||||||||||||||||
| Property, Plant and Equipment, Net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Developed Technology, Net | ||||||||||||||||||||
| Customer Relationships, Net | ||||||||||||||||||||
| Other Intangibles, Net | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Noncurrent Assets of Discontinued Operations | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Current debt obligations | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Salaries, wages and related items | ||||||||||||||||||||
| Income taxes | ||||||||||||||||||||
| Payables, accrued expenses and other current liabilities | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-Term Debt | ||||||||||||||||||||
| Long-Term Employee Benefit Obligations | ||||||||||||||||||||
| Deferred Income Taxes and Other Liabilities | ||||||||||||||||||||
| Noncurrent Liabilities of Discontinued Operations | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Preferred Stock, Value, Issued | ||||||||||||||||||||
| Common stock — $1 par value; authorized — 640,000,000 shares; issued — 370,594,401 shares in June 30, 2026 and September 30, 2025 | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Deferred compensation | ||||||||||||||||||||
| Treasury stock | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Common stock, par value (USD per share) | ||||||||||||||||||||
| Common stock, shares authorized (shares) | ||||||||||||||||||||
| Common stock, shares issued (shares) | ||||||||||||||||||||
Loading...
